<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(1)</volume><submitter>Srivastava T</submitter><pubmed_abstract>This scoping review identifies the construction and defined purpose of disadvantage indices deployed during the initial COVID-19 vaccine rollout.</pubmed_abstract><journal>JAMA health forum</journal><pagination>e214501</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8903102</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Disadvantage Indices Deployed to Promote Equitable Allocation of COVID-19 Vaccines in the US: A Scoping Review of Differences and Similarities in Design.</pubmed_title><pmcid>PMC8903102</pmcid><pubmed_authors>Srivastava T</pubmed_authors><pubmed_authors>Sadecki E</pubmed_authors><pubmed_authors>Kornides ML</pubmed_authors><pubmed_authors>Schmidt H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Disadvantage Indices Deployed to Promote Equitable Allocation of COVID-19 Vaccines in the US: A Scoping Review of Differences and Similarities in Design.</name><description>This scoping review identifies the construction and defined purpose of disadvantage indices deployed during the initial COVID-19 vaccine rollout.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-03T22:25:01.978Z</modification><creation>2024-10-15T21:32:25.56Z</creation></dates><accession>S-EPMC8903102</accession><cross_references><pubmed>35977227</pubmed><doi>10.1001/jamahealthforum.2021.4501</doi></cross_references></HashMap>